LocalNavigation

Seize the Moment: Opportunities for Green Chemistry and Green Engineering in the Pharmaceutical Industry

Agenda and Presentations

Note: Presentations posted only as available, with permission of speaker.

You will need Adobe Acrobat Reader, available as a free download, to view some of the files on this page. See EPA's PDF page to learn more about PDF, and for a link to the free Acrobat Reader.

7:30AM REGISTRATION
8:00AM Welcome/Introduction
Kathleen Callahan, Deputy Regional Administrator, EPA Region 2
D. Christopher Watts, Standards & Technology, FDA Center for Drug Evaluation and Research/Office of Pharmaceutical Science
8:30AM Session 1: The Pharmaceutical Industry—Environmental Footprint
This session examines the environmental footprint of manufacturing processes associated with the pharmaceutical industry. EPA, FDA, and industry provide perspectives on opportunities and challenges to achieving sustainability in the industry.
  • Sharon Austin (PDF) (10 pp, 186K), EPA Office of Pollution Prevention and Toxics
  • David J. C. Constable (PDF) (14 pp, 787K), GlaxoSmithKline
  • D. Christopher Watts (PDF) (8 pp, 304K), Standards & Technology, FDA Center for Drug Evaluation and Research/Office of Pharmaceutical Science
    		•
    10:00AM BREAK (Networking)
    10:30AM Session 2: Green Chemistry and Green Engineering in the Pharmaceutical Industry
    This session provides knowledge on green chemistry and green engineering principles that leads to best design chemistry and process efficiencies.
  • Richard Engler (PDF) (7 pp, 131K), EPA Office of Pollution Prevention and Toxics
    		•
    11:00AM Session 3: Green Chemistry/Green Engineering Technical Approaches
    This session showcases some synthesis pathways, process routes, technologies and other technical approaches that improve chemical design and process efficiency.
  • John Leazer, Merck & Co., Inc.
  • John Tucker (PDF) (13 pp, 323K), BioVerdant, Inc.
    		•
    12:00PM LUNCH
    Lunch will include an opportunity for networking with your colleagues.
    1:30PM Session 4: Exemplary Practices of Green Chemistry and Green Engineering
    This session features inspirational change agents from the pharmaceutical industry that will share their experiences, collaborative efforts, accomplishments to date, and relevance to diverse audiences.
  • Berkeley W. Cue, Jr., ACS Green Chemistry Institute, Pharmaceutical Roundtable Association
  • Stephan P. Taylor, Bristol-Myers Squibb Company
    		•
    2:30PM BREAK (Networking)
    3:00PM Session 5: Facilitated Dialogue—How to Better Promote Green Chemistry and Green Engineering in the Pharmaceutical Industry
    This session explores ideas on how to better promote green chemistry and green engineering in manufacturing processes associated with the pharmaceutical industry.
  • Introduction by Walter Schoepf, EPA Region 2 and Ann Lee-Jeffs, Johnson and Johnson Worldwide
    		•
    5:00PM Closing Remarks
    Nhan T. Nguyen, EPA Office of Pollution Prevention and Toxics
    5:30PM ADJOURN

    Jump to main content.

    Jump to main content.